CanSino Biologics Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
9.87 | 35.42 | -72.13% | -29.2 | -133.81% |
| P/S |
|
14.2 | 7.59 | 87.13% |
|
|
| P/BV |
|
0.927 | 3.68 | -74.84% |
|
|
| P/FCF |
|
-7.78 | 55.38 | -114.04% |
|
|
| Ev/Ebitda |
|
-11.93 | 2.91 | -510.26% |
|
|
| Ev/S |
|
15.4 | 23.72 | -35.08% |
|
|
| Ev/FCF |
|
-2.79 | 63.78 | -104.38% |
|
|
| E/P |
|
-0.1002 | 0.0326 | -407.21% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-274.15 | -13.64 | 1909.46% | -2096.05 | -86.92% |
| ROE |
|
-24.67 | 5.19 | -575.57% |
|
|
| ROA |
|
-14.27 | 3.47 | -511.16% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
-429.55 | -11.49 | 3639.49% |
|
|
| ROCE |
|
0 | 0.2627 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-2.87 | 0.7755 | -470.65% | -2.54 | +13.2% |
| Nеt Debt/Ebitda |
|
-0.437 | 0.0127 | -3528.35% |
|
|
| Debt/Ratio |
|
0.2919 | 0.1229 | 137.59% |
|
|
| Debt/Equity |
|
0.8553 | 0.8005 | 6.86% |
|
|
| Debt/Net Income |
|
-1.83 | 1.76 | -204.38% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 5.7 | -100% | 1.85 | -100% |
| Number of years of dividend growth |
|
1 | 1.13 | -11.11% | ||
| DSI |
|
0.5 | 0.5838 | -14.35% |
|
|
| Average dividend growth |
|
0 | 3.2 | -100% |
|
|
| Average percentage for 5 years |
|
1.85 | 4.95 | -62.71% |
|
|
| Average percentage for payments |
|
0.7364 | 23.96 | -96.93% |
|
|
| Difference from average difference in sector |
|
-5.7 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
15017.07 | 21.26 | 70535.32% | ||
| Growth impulse Ebitda in 5 years |
|
531.31 | -43.94 | -1309.17% | ||
| Growth impulse Net Income in 5 years |
|
845.82 | 83.64 | 911.26% | ||
| Growth impulse FCF in 5 years |
|
562.73 | 79.76 | 605.53% | ||
| Growth impulse EPS in 5 years |
|
735.01 | -117.1 | -727.68% |
IP Score
5.4/10
